IperionX grants performance-based options and rights to director Hannigan

Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An update from Iperionx Limited ( (AU:IPX) ) is now available.

IperionX Limited has updated the market on changes to director Todd Hannigan’s interests, confirming the issue of new options and performance rights as part of his compensation package. The equity awards, which carry exercise prices of A$18.00 and A$22.00 and performance hurdles tied to future share price and continued service, were granted for nil cash consideration following shareholder approval at the 19 March 2026 general meeting, further increasing Hannigan’s exposure to the company’s long-term performance.

Following the transaction, Hannigan’s holdings now include more than 25.6 million ordinary shares, 50,000 ADSs, 454,464 RSUs and a substantial suite of options and performance rights with varying strike prices and vesting conditions. The grant underscores IperionX’s ongoing use of performance-based equity to incentivize key leadership and could have a modest dilutive effect for shareholders over time if vesting conditions are met and the instruments convert into ordinary shares.

The most recent analyst rating on (AU:IPX) stock is a Hold with a A$3.00 price target. To see the full list of analyst forecasts on Iperionx Limited stock, see the AU:IPX Stock Forecast page.

IperionX Limited operates in the metals and materials sector, focusing on advanced titanium and related technologies. The company is listed on the ASX and uses equity-based incentives, including shares, American Depositary Shares, restricted stock units, options and performance rights, to align executive compensation with shareholder interests.

Learn more about IPX stock on TipRanks’ Stock Analysis page.…Read more by TipRanks Australian Auto-Generated Newsdesk